Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | BioTech • Medical Devices (& Hospital Services) |
Investing | United States • Canada • South Africa |
Novax AB is a private equity fund based in Stockholm, Sweden, that takes an active and long-term approach to investing in, supporting, and developing small to medium-sized enterprises (SMEs) with the aim of contributing to their success and establishing them as future pillars for Axel Johnson. With a focus on growth and a hands-on engagement style, Novax collaborates closely with its portfolio companies, offering practical support, advice, knowledge, and resources. They invest in both early and later stages, focusing on sectors rather than company size or stage, guided by the potential of the team and business. They only invest in industries they believe will contribute to building a more sustainable society. Novax operates predominantly within four main sectors: preventive health, energy of the future, technical security, and food of the future. They are actively seeking disruptive and innovative ideas in sustainable energy, food entrepreneurs committed to reducing waste and emissions while improving efficiency, security businesses that offer valuable and smart services, and healthcare services that promote a more active and healthier lifestyle. Moreover, Novax engages in opportunistic investments aimed at companies with the capacity to become new sector foundations and make significant contributions to the Novax ecosystem. As a part of the Axel Johnson Group, Novax is supported by a wider network, offering exchanges of knowledge and collective problem-solving, with the goal of fostering an ecosystem where companies and individuals can flourish and reach their growth potential.